Candida dubliniensis fungemia: The first four cases in North America

Emerging Infectious Diseases

Volumn 6, Issue 1, 2000, Pages 46-49

  Brandt, Mary E ^a   Harrison, Lee H ^b,c   Pass, Margaret ^b   Sofair, Andre N ^d   Huie, Sharon ^d   Li, Ren Kai ^a   Morrison, Christine J ^a   Warnock, David W ^a   Hajjeh, Rana A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANDIDA DUBLINIENSIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FUNGEMIA; FUNGUS CULTURE; HUMAN; MALE; PREVALENCE;

EID: 0034003293     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0601.000108     Document Type: Article

References (14)

1. Coleman DC, Rinaldi MG, Haynes KA, Rex JH, Summerbell RC, Anaissie EJ, et al. Importance of Candida species other than Candida albicans as opportunistic pathogens. Medical Mycology 1998;36 Suppl 1:156-65.
2. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995;141:1507-21.
3. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997;11:557-67.
4. Sullivan D, Coleman D. Candida dubliniensis-characteristics and identification. J Clin Microbiol 1998;36:329-34.
5. Sullivan D, Haynes K, Bille J, Boerlin P, Rodero L, Lloyd S, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997;35:960-4.
6. Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock culture collection J Clin Microbiol 1998;36:2869-73.
7. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997;41:616-23.
8. Meis JFGM, Ruhnke M, DePauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation Emerg Infect Dis 1999;5:150-3.
9. Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 1998;36:1467.
10. Elie CM, Lott TJ, Reiss E, Morrison CJ. Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol 1998;36:3260-5.
11. Boucher H, Mercure S, Montplaisir S, Lemay G. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene 1996;180:189-96.
12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A. Wayne (PA): The Committee;1997.
13. Elie CM, Kao AS, Hajjeh RA, Brandt ME, Pruitt WR, Reiss E, et al. Examination of bloodstream yeast isolates for the presence of the recently described Candida species, C. dubliniensis, as part of a prospective, population-based surveillance study. In: Abstracts of the Fifth Candida and Candidiasis Conference, 1999. Abstract C41, p. 60. Washington: American Society for Microbiology.
14. Cole GT, Halawa AL, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996;22 Suppl 2:S73-88.